A detailed history of High Tower Advisors, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, High Tower Advisors, LLC holds 196,212 shares of RPRX stock, worth $5.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
196,212
Previous 224,424 12.57%
Holding current value
$5.2 Million
Previous $6.82 Million 24.08%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$26.26 - $29.9 $740,847 - $843,538
-28,212 Reduced 12.57%
196,212 $5.17 Million
Q1 2024

May 06, 2024

BUY
$27.46 - $31.33 $1.35 Million - $1.54 Million
49,028 Added 27.95%
224,424 $6.82 Million
Q4 2023

Feb 12, 2024

SELL
$26.21 - $29.22 $1.46 Million - $1.63 Million
-55,748 Reduced 24.12%
175,396 $4.93 Million
Q3 2023

Nov 08, 2023

BUY
$26.26 - $31.38 $1.83 Million - $2.18 Million
69,527 Added 43.02%
231,144 $6.27 Million
Q2 2023

Aug 14, 2023

SELL
$29.6 - $36.56 $72,638 - $89,718
-2,454 Reduced 1.5%
161,617 $4.97 Million
Q1 2023

May 11, 2023

BUY
$32.77 - $39.4 $167,716 - $201,649
5,118 Added 3.22%
164,071 $5.91 Million
Q4 2022

Feb 08, 2023

SELL
$39.17 - $44.04 $346,576 - $389,665
-8,848 Reduced 5.27%
158,953 $6.28 Million
Q3 2022

Nov 09, 2022

BUY
$39.88 - $44.65 $31,584 - $35,362
792 Added 0.47%
167,801 $6.74 Million
Q2 2022

Aug 10, 2022

BUY
$37.53 - $44.22 $574,321 - $676,698
15,303 Added 10.09%
167,009 $7.02 Million
Q1 2022

May 12, 2022

BUY
$37.46 - $42.44 $765,307 - $867,049
20,430 Added 15.56%
151,706 $5.92 Million
Q4 2021

Feb 10, 2022

BUY
$35.17 - $42.48 $381,981 - $461,375
10,861 Added 9.02%
131,276 $5.24 Million
Q3 2021

Nov 12, 2021

BUY
$36.14 - $42.24 $72,569 - $84,817
2,008 Added 1.7%
120,415 $4.36 Million
Q2 2021

Aug 06, 2021

BUY
$39.85 - $46.63 $4.72 Million - $5.52 Million
118,407 New
118,407 $4.85 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.